Carl L. Gordon, Director, 10% Owner at Theseus Pharmaceuticals, Inc. (THRX), bought 281,834 shares at $9.95 ($2.8M) on 2022-01-20, disclosed to the SEC on 2022-01-21.
Open-market purchase of $2.8M THRX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.97 | 11,521 | $115K | 4.1% |
| 2 | $9.97 | 11,521 | $115K | 4.1% |
| 3 | $9.95 | 35,000 | $348K | 12.4% |
| 4 | $9.97 | 111,896 | $1.1M | 39.7% |
| 5 | $9.97 | 111,896 | $1.1M | 39.7% |
| Total | $9.97 avg | 281,834 |
| $2.8M |
| 100% |
| Filing → |
| SCTX | BUY | 2026-07-29 | $15.0M | — | Filing → |
| CMPX | SELL | 2025-04-11 | $11.4M | — | Filing → |
| MBX | BUY | 2025-02-19 | $2.7M | — | Filing → |